Lactobacillus acidophilus NCFM and Probiotics: what the published research says
PubMed indexes 8 records that name Lactobacillus acidophilus NCFM and Probiotics together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.
Every statement below is attributed to a named, dated, linked source.
This page lists published research relevant to Lactobacillus acidophilus NCFM and Probiotics. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.
A study appearing here is not proof that an interaction exists. Two substances can be named together in a paper that never tested them in combination, and a source listed as background may cover only one of them.
Findings are quoted from each abstract as the authors wrote them. NutriStack has not re-analysed, pooled, or reconciled them, and they may disagree with each other.
NutriStack’s own interaction assessment for this pair is not published here. It has not completed qualified-human clinical review, so it is withheld from search. See the publication gate.
Nothing here is medical advice. Decisions about prescription medication and supplements belong with your prescriber or pharmacist, who can see your full regimen.
The research
8 studies naming Lactobacillus acidophilus NCFM and Probiotics.
Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.
“The product containing yogurt with polydextrose, B. lactis HN019 and L. acidophilus NCFM® significantly shortened colonic transit time after two weeks in the TG compared to CG and may be an option for treatment of constipation.”
Names both Lactobacillus acidophilus NCFM and Probiotics in its title.
Brain, behavior, and immunity · 2026 · PMID 41513011
Animal study
“The relative abundances of propionate- and butyrate-producing bacteria, their biosynthetic pathways, and the critical enzymes were all elevated in the gut microbiota of probiotic-treated mice. These findings suggest that the probiotic cocktail exerts strong anti-inflammatory effects in both the colon and SN by enhancing microbial production of propionate and butyrate and suppressing activation of the TLR2/TLR4-NF-κB pathway.”
Names both Lactobacillus acidophilus NCFM and Probiotics in its title.
“This study provides a comparative analysis of the currently available genomes for L. acidophilus and examines microevolution patterns for several strains derived from L. acidophilus NCFM, which revealed no to very few SNPs with strains sequenced at different points in time using different sequencing technologies and platforms.”
Names both Lactobacillus acidophilus NCFM and Probiotics in its title.
Frontiers in cellular and infection microbiology · 2023 · PMID 37621875
Human subjects
“L. acidophilus NCFM and L. plantarum Lp-115 can reduce the adhesion of H. pylori and inhibit the gastric inflammatory response caused by H. pylori infection.”
Names both Lactobacillus acidophilus NCFM and Probiotics in its title.
Probiotics and antimicrobial proteins · 2023 · PMID 36376613
Human subjects
“Meanwhile, resveratrol promotes expression and glycosylation of mucins in HT-29 cells. Our findings provide theoretical support for an in-depth explanation of the interaction among resveratrol, NCFM, and the HT-29 cells.”
Names both Lactobacillus acidophilus NCFM and Probiotics in its title.
“To summarize, expression of the galU gene can significantly enhance gene expression in galactose metabolic pathway and make the strain form a stronger cell wall and cell capsule and enhance the resistance of the bacteria to an adverse external environment, to improve the freeze-drying survival rate of L. acidophilus NCFM.”
Names both Lactobacillus acidophilus NCFM and Probiotics in its title.
Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022 · PMID 35094300
“The probiotic performance of the isolates was mainly dependent on strain specificity. The results obtained in this work can foster the revalorization of pulque as a functional natural product.”
Names both Lactobacillus acidophilus NCFM and Probiotics in its title.
Limitations
What this evidence cannot tell you.
Search-based evidence indexes have real limits, and it is worth being explicit about them:
Selection. These records were found by searching PubMed titles and abstracts for both substance names alongside interaction and pharmacokinetic terms. Relevant work that phrases things differently, or is not indexed in PubMed, will be missing.
No effect size. The quoted conclusions are the authors’ words about their own study. We have not extracted effect direction or magnitude, and a single study’s conclusion is not a consensus.
Population mismatch. Findings in healthy volunteers, animals, or a specific patient group may not transfer to you, your dose, or your formulation.
Absence is not safety. Few published studies means the combination is under-studied, which is not the same as established as safe.
Nearby evidence
Other pairs with published research.
Pages covering Lactobacillus acidophilus NCFM or Probiotics alongside a different substance.
NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Lactobacillus acidophilus NCFM, Probiotics, and several hundred other substances.
The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
